Abstract
Imagine you admit a patient with a bleeding gastric ulcer. The patient is not taking aspirin or non-aspirin non-steroidal anti-inflammatory drugs (NSAIDs). What do you do to prevent further ulceration and ulcer complications? Probably, all would seek to eradicate the causative Helicobacter pylori, as this is logical, intellectually coherent and supported by pragmatic experience. You know that H. pylori eradication on its own will lead to ulcer healing but the patient has had a bleed and you want him/her to be safe so, in addition, you give an ulcer-healing agent, at least until ulcer healing has occurred.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Graham DY, Lidsky MD, Cox AM et al. Long-term non-steroidal anti-inflammatory drug use and Helicobacter pylori infection. Gastroenterology. 1991;100:1653.
Kim JG, Graham DY. Helicobacter pylori infection and development of gastric or duodenal ulcer in arthritic patients receiving chronic NSAID therapy. The Misoprostol Study Group. Am J Gastroenterol. 1994;89:203.
Hudson N, Taha AS, Russell RI et al. Famotidine for healing and maintenance in nonsteroidal anti-inflammatory drug-associated gastroduodenal ulceration. Gastroenterology. 1997;112:1819.
Hawkey CJ, Karrasch JA, Szczepanski L et al. Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. N Engl J Med. 1998;338:727.
Yeomans ND, Tulassay Z, Juhasz L et al. A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. N Engl J Med. 1998;338:719.
Cullen D, Bardhan KD, Eisner M et al. Primary gastroduodenal prophylaxis with omeprazole for non-steroidal anti-inflammatory drug users. Aliment Pharmacol Ther. 1998;12:135.
Bianchi Porro G, Parente F, Imbesi V et al. Role of Helicobacter pylori in ulcer healing and recurrence of gastric and duodenal ulcers in longterm NSAID users. Response to omeprazole dual therapy. Gut. 1996;39:22.
Chan FK, Sung JJ, Suen R et al. Does eradication of Helicobacter pylori impair healing of nonsteroidal anti-inflammatory drug associated bleeding peptic ulcers? A prospective randomized study. Aliment Pharmacol Ther. 1998; 12:1201.
Hawkey CJ, Tulassay Z, Szczepanski L et al. Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study. Lancet. 1998;352:1016.
Labenz J, Tillenburg B, Peitz U et al. Irreversible fall of efficacy of omeprazole after cure of H. pylori infection in duodenal ulcer patients. Gastroenterology. 1996;110:A165.
Labenz J, Tillenburg B, Peitz U, Verdu E, Stolte M, Borsch G, Blum AL. Effect of curing Helicobacter pylori infection on intragastric acidity during treatment with ranitidine in patients with duodenal ulcer. Gut. 1997;41:33–36.
Yanaka A, Nakahara A, Tanaka N et al. Eradication of Helicobacter pylori does not prevent ulcer relapse in patients with NSAIDs-induced gastric ulcer. Gastroenterology. 1999; 116, A362.
Chan FKL, Sung JY, Suen R et al. Eradication of H. pylori versus maintenance acid suppression to prevent recurrent ulcer hemorrhage in high-risk NSAID users: a prospective randomized study. Gastroenterology. 1998;114:A87.
Chan FKL, Sung JYJ, Ching JYL et al. Prospective randomised trial of misoprostol plus naproxen versus nabumetone to prevent recurrent ulcer haemorrhage in high-risk NSAID users. Gastroenterology. 1999;116:A134.
Silverstein FE, Graham DY, Senior JR et al. Misoprostol reduces serious gastrointestinal complications in patients with arthritis receiving non steroidal antiinflammatory drugs — a randomised double blind placebo controlled study. Ann Intern Med. 1995;123:241–249.
Chan FK, Sung JJ, Chung SC et al. Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers. Lancet. 1997;350:975.
Huang JQ, Lad RJ, Sridhar S, Sumanac K, Hunt RH. H. pylori infection increases the risk of non-steroidal anti-inflammatory drug (NSAID)-induced gastro-duodenal ulceration. Gastroenterology. 1999;116:A192.
Cullen DJ, Hawkey GM, Greenwood DC et al. Peptic ulcer bleeding in the elderly: relative roles of Helicobacter pylori and non-steroidal anti-inflammatory drugs. Gut. 1997;41:459.
Aalykke C, Lauritsen JM, Hallas J et al. Helicobacter pylori and risk of ulcer bleeding among users of nonsteroidal anti-inflammatory drugs: a case-control study. Gastroenterology. 1999;116:1305.
Labenz J, Peitz U, Kohl H et al. Helicobacter pylori increases the risk of peptic ulcer bleeding: a case-control study. Ital J Gastroenterol Hepatol. 1999;31:110.
Pilotto A, Leandro G, Di Mario F et al.: Role of Helicobacter pylori infection on upper gastrointestinal bleeding in the elderly: a case-control study. Dig Dis Sci. 1997;42:586.
Wu CY, Poon SK, Chen GH et al. Interaction between Helicobacter pylori and non-steroidal anti-inflammatory drugs in peptic ulcer bleeding. Scand J Gastroenterol. 1999;34:234.
Stack WA, Hawkey GM, Atherton JC et al. Interaction of risk factors for peptic ulcer bleeding. Gastroenterology. 1999;116:A97.
Santolaria S, Lanas A, Benito R et al. Helicobacter pylori infection is a protective factor for bleeding gastric ulcers but is not for bleeding duodenal ulcers in NSAID users. Gastroenterology. 1999;116:A231.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Hawkey, C.J. (2000). Helicobacter pylori and non-steroidal anti-inflammatory drugs. In: Hunt, R.H., Tytgat, G.N.J. (eds) Helicobacter pylori. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-3927-4_49
Download citation
DOI: https://doi.org/10.1007/978-94-011-3927-4_49
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-5753-0
Online ISBN: 978-94-011-3927-4
eBook Packages: Springer Book Archive